Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
06/2002
06/19/2002CN1354792A Biosynthesis of foreign proteins using transformed microalgae
06/19/2002CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use
06/19/2002CN1354790A Transformant for screening of inhibitors for human immunodeficiency virus
06/19/2002CN1354789A Polypeptides having choline oxidase activity and nucleic acid encoding same
06/19/2002CN1354788A Cyclic peptides
06/19/2002CN1354786A Method of high-concentration culture of nitrifying bacteria or denitrifying bacteria contained in activated sludge, culture promoter to be used in high-concentration culture method of nitrifying
06/19/2002CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon
06/19/2002CN1354668A Isolated peptides which bind to HLA-B35 molecules
06/19/2002CN1354252A Culture of ramaria mycorrhizal fungi by using glass bead as culture medium
06/19/2002CN1086421C Synthesis and clone of composite polyvalent vaccine gene for type-C hepatitis virus
06/18/2002US6407046 Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
06/18/2002US6406909 Soybean protein hydrolysate, yeast extract and wheat protein hydrolysate
06/18/2002US6406899 Highly active alkaline phosphatase
06/18/2002US6406898 Recombinant protein with pantolactone activity
06/18/2002US6406884 Isolated nucleic acid sequence of cdna insert of plasmid
06/18/2002US6406871 Method for detecting ligand binding to G protein coupled receptors
06/18/2002US6406847 Mismatch repair detection
06/18/2002US6406723 Method for preparing flour doughs and products made from such doughs using glycerol oxidase and lipase
06/18/2002US6406700 Antigrowth agents for cancer, heat shock proteins bonding to proteins, complexes
06/18/2002CA2091907C Stable propagation of modified full length cystic fibrosis transmembrane conductance regulator protein cdna in heterologous systems
06/18/2002CA2090122C Recombinant yeasts containing the dna sequences coding for xylose reductase-and xylitol dehydrogenase enzymes
06/13/2002WO2002046475A2 Method of detecting and treating tuberous sclerosis complex associated disorders
06/13/2002WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
06/13/2002WO2002046455A2 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
06/13/2002WO2002046441A2 Targets for herbicides and transgenic plants resistant to said herbicides
06/13/2002WO2002046437A2 Methods and compositions for highly efficient production of heterologous proteins in yeast
06/13/2002WO2002046435A2 Engineered plasmids and their use for in situ production of genes
06/13/2002WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
06/13/2002WO2002046418A2 Lipid-associated molecules
06/13/2002WO2002046417A2 Adipocyte complement related protein zacrp3x2
06/13/2002WO2002046411A2 Intestinal proteins
06/13/2002WO2002046409A2 Proteins and nucleic acids encoding same
06/13/2002WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
06/13/2002WO2002046405A1 Process for producing rfrp
06/13/2002WO2002046404A2 Schizophrenia-related voltage-gated ion channel gene and protein
06/13/2002WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
06/13/2002WO2002046385A2 Enzymes
06/13/2002WO2002046384A2 Kinases and phosphatases sequences, and use thereof
06/13/2002WO2002046383A2 Protein modification and maintenance molecules
06/13/2002WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/13/2002WO2002046381A2 Method for the prevention or reduction of haze in beverages
06/13/2002WO2002046379A2 Glucuronyl c5-epimerase, dna encoding the same and uses thereof
06/13/2002WO2002046372A1 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
06/13/2002WO2002046371A1 Dual substrate cultivation
06/13/2002WO2002046370A1 Promoter for the culture of autrotrophic bacterium at high density
06/13/2002WO2002046369A2 Yeast-based assays involving gpcrs
06/13/2002WO2002046362A2 Gene associated with benign prostatic hyperplasia in humans
06/13/2002WO2002046360A2 Methods for producing tuberculosis causative agent on a culture medium, culture medium for producing the tuberculosis causative agent, method for producing said medium and growth stimulator for the tuberculosis causative agent
06/13/2002WO2002046354A2 Automated imaging and harvesting of colonies of thin film culture devices
06/13/2002WO2002046353A2 Self-spreading microbiological culture device
06/13/2002WO2002046238A2 Rationally designed antibodies
06/13/2002WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide
06/13/2002WO2002046232A2 Multimeric single-chain antibody with multiple antigen binding
06/13/2002WO2002046230A2 G-protein coupled receptors
06/13/2002WO2002046224A2 Compositions and methods relating to lung specific genes and proteins
06/13/2002WO2002046216A2 Human sprouty-4 polypeptide
06/13/2002WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2002WO2002046212A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002WO2002046208A2 Method of producing biospecific molecules by protein trans-splicing
06/13/2002WO2002046152A2 Coniosetin and derivatives thereof, method for producing the same and use thereof
06/13/2002WO2002045826A1 Biofilter equipped with a stirrer and injector of solid feed and method for removing odor and volatile organic compounds from waste gases using the same
06/13/2002WO2002045738A2 Vaccine composition containing transforming growth factor alpha
06/13/2002WO2002045736A1 Methods for improved diagnosis and treatment of mycobacterial infections
06/13/2002WO2002045524A2 Prolyl endoprotease from aspergillus niger
06/13/2002WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
06/13/2002WO2002029029A3 Nucleotide sequences which code for the cysd, cysn, cysk, cyse and cysh genes of c. glutamicum
06/13/2002WO2002028419A3 Chemokine mutants in the treatment of multiple sclerosis
06/13/2002WO2002026929A3 Kini-3 motor protein and methods for its use
06/13/2002WO2002022632A3 Nucleotide sequences coding for the pknd gene
06/13/2002WO2002020793A8 Chra of corynebacterium glutamicum
06/13/2002WO2002020038A3 Method for down-regulating ige
06/13/2002WO2002017948A3 Control of crop pests and animal parasites through direct neuronal uptake
06/13/2002WO2002012339A3 Sequences for integrin alpha-8
06/13/2002WO2002004495A3 Streptococcus pyogenes antigen
06/13/2002WO2002000858A3 Methods and compositions for simultaneous saccharification and fermentation
06/13/2002WO2001096377A3 Vaccine for congenital tremors in pigs
06/13/2002WO2001094547A3 Molecular delivery vehicle for delivery of selected compounds to targets
06/13/2002WO2001094415A3 Nuclear hormone receptor
06/13/2002WO2001090188A3 Receptor-based interaction trap
06/13/2002WO2001083785A3 Regulated antigen delivery system (rads) involving bacteria
06/13/2002WO2001064889A3 Tnf-alpha variants for the treatment of tnf-alpha related disorders
06/13/2002WO2001057242A3 Methods of protein destabilization and uses thereof
06/13/2002WO2001049854A3 Increased lysine production by gene amplification using coryneform bacteria
06/13/2002WO2001044300A3 Brain specific binding members
06/13/2002WO2001042461A3 Apoptin-associating protein
06/13/2002WO2000078994A9 Compositions and methods for the quantification of sterol biosynthetic flux
06/13/2002WO2000077262A9 Synthetic ligation reassembly in directed evolution
06/13/2002WO2000037610A3 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/13/2002US20020073447 Acquired resistance genes and uses thereof
06/13/2002US20020072596 Nucleotide sequences coding transrerrins; for use in the treatment of nervous system., blood abbd anemia, heme biosynthesis disorders
06/13/2002US20020072595 Nucleic acid for use in kits for detection of preferential bacterial infection
06/13/2002US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen
06/13/2002US20020072491 Homology to members of the myosin light chain kinase subfamily
06/13/2002US20020072488 Amino acid sequences of human transporter peptides and proteins that are related to the sugar transporter subfamily; identifying modulators of the transporter peptides
06/13/2002US20020072114 Self-spreading microbiological culture device
06/13/2002US20020072107 Human osteoclast derived cathepsin
06/13/2002US20020072106 Peptides selected by homology and/or structural relatedness to known protease proteins of the choriolytic hatching protease subfamily and expression pattern observed
06/13/2002US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels
06/13/2002US20020072098 Generation of threonine; obtain cells, transform with vector coding threonine, ferment, recover threonine